Is a
Patent attributes
Patent Jurisdiction
Patent Number
Patent Inventor Names
Chao Zhou0
Zhixiang Zheng0
Norman Xianglong Kong0
Date of Patent
March 17, 2020
0Patent Application Number
162462360
Date Filed
January 11, 2019
0Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to a heterocyclic compound, a pharmaceutical composition containing the same, a preparation method thereof, and use thereof as a fibroblast growth factor receptor (FGFR) inhibitor. The compound is a heterocyclic compound as shown in Formula I, or a pharmaceutically acceptable salt, prodrug, solvent compound, polymorph, isomer or stable isotopic derivative thereof. The present invention further relates to use of the compound for the treatment or prevention of related diseases which are FGFR-mediated such as cancer, and a method for applying the compound to treat said diseases.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
